Skip to main content
TipRanks
Go Ultimate75% OFF

Newron Pharmaceuticals SpA (NWPHF) Stock Forecast & Price Target

20 Followers
See the Price Targets and Ratings of:

NWPHF Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Newron Pharmaceuticals SpA in the past 3 months

NWPHF Stock 12 Month Forecast

$29.21▲(46.06% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Newron Pharmaceuticals SpA in the last 3 months. The average price target is $29.21 with a high forecast of $35.77 and a low forecast of $22.65. The average price target represents a 46.06% change from the last price of $20.00.
Highest Price Target$35.77Average Price Target$29.21Lowest Price Target$22.65

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NWPHF
Price TargetArticle
H.C. Wainwright$31.00→$35.77buy78.84%UpsideReiterated10/22/26
Roth MKM$22.65buy13.27%UpsideAssigned10/05/26
Lucid Capital―buy―Initiated12/11/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Newron Pharmaceuticals SpA

3 Months
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate2/8 ratings generated profit
25%
Average Return
+28.40%

Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +28.40% per trade.

1 Year
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate3/8 ratings generated profit
38%
Average Return
+42.60%

Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +42.60% per trade.

2 Years
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate3/8 ratings generated profit
38%
Average Return
+42.60%

Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of +42.60% per trade.

NWPHF Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for NWPHF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy54233
Buy00011
Hold00000
Sell00000
Strong Sell00000
total54244

In the current month, NWPHF has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NWPHF average Analyst price target in the past 3 months is 29.21.

NWPHF Financial Forecast

$-3$-1.75$-0.5$0.75$2Q2 2025Q2 2026Q4 2026
High$-0.54
Consensus$-0.86
Low$-1.14

NWPHF Earnings Forecast

Next quarter’s earnings estimate for NWPHF is -$0.86 with a range of -$1.14 to -$0.54. The previous quarter’s EPS was -$0.90. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$3.5M$16.4M$29.2M$42M$54.8MQ2 2025Q2 2026Q4 2026
High$11.5M
Consensus$8.91M
Low$5.61M

NWPHF Sales Forecast

Next quarter’s sales forecast for NWPHF is $8.91M with a range of $5.61M to $11.45M. The previous quarter’s sales results were $3.54M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NWPHF Stock Forecast FAQ

What is NWPHF’s average 12-month price target, according to analysts?
Based on analyst ratings, Newron Pharmaceuticals SpA’s 12-month average price target is $29.21.
What is NWPHF’s upside potential, based on the analysts’ average price target?
Newron Pharmaceuticals SpA has 46.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NWPHF a Buy, Sell or Hold?
Newron Pharmaceuticals SpA has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Newron Pharmaceuticals SpA’s price target?
The average price target for Newron Pharmaceuticals SpA is $29.21. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $35.77, the lowest forecast is $22.65. The average price target represents a 46.06% increase from the current price of $20.
What do analysts say about Newron Pharmaceuticals SpA?
Newron Pharmaceuticals SpA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of NWPHF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.